logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10548930 B1

PDFFull Text
Date of Patent:
Feb. 04, 2020

Filed:

Apr. 18, 2016

Use of mva or mvaΔe3l as immunotherapeutic agents against solid tumors

Applicant:

Memorial Sloan Kettering Cancer Center, New York, NY (US);

Inventors:

Liang Deng, New York, NY (US);

Jedd Wolchok, New York, NY (US);

Taha Merghoub, New York, NY (US);

Stewart Shuman, New York, NY (US);

Peihong Dai, New York, NY (US);

Weiyi Wang, New York, NY (US);

Assignee:

Memorial Sloan Kettering Cancer Center, New York, NY (US);

Attorney:

Foley & Lardner LLP

Primary Examiner:

Michelle S Horning

Int. Cl.
CPC ...
A61K 39/12 (2006.01); A61K 35/768 (2015.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/768 (2013.01); A61K 39/12 (2013.01); A61K 39/3955 (2013.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); A61K 2039/505 (2013.01); A61K 2039/525 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/57 (2013.01); C12N 2710/24122 (2013.01); C12N 2710/24132 (2013.01); C12N 2710/24134 (2013.01); C12N 2710/24171 (2013.01);
Abstract

The present disclosure relates to modified vaccinia Ankara (MVA) virus or MVAAE3L delivered intratumorally or systemically as an anticancer immunotherapeutic agent, alone, or in combination with one or more immune checkpoint blocking agents for the treatment of malignant solid tumors. Particular embodiments relate to mobilizing the host's immune system to mount an immune response against the tumor.

Find Patent Forward Citations

Deng, Liang. (2020). Use of mva or mvaΔe3l as immunotherapeutic agents against solid tumors (U.S. Patent No. 10548930). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10548930

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…